Adelene Q. Perkins, President & Chief Executive Officer at INFINITY PHARMACEUTICALS, INC. (INFI), bought 50,000 shares at $4.89 ($245K) on 2010-08-24, disclosed to the SEC on 2010-08-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.89 | 44,651 | $218K | 89.1% |
| 2 | $4.99 | 5,349 | $27K | 10.9% |
| Total | $4.90 avg | 50,000 | $245K | 100% |
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |